CCN3 and prostate cancer: CCN3 may inhibit the activity of NOTCH1 by binding to the extracellular domain of NOTCH1 in CML [21], and the CCN3 protein secreted by prostate cancer (PCa) could recruit macrophages and promote their differentiation into the M2 phenotype [22].